share_log

Arcutis Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Burnett Patrick

Arcutis Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Burnett Patrick

Arcutis Biotherapeutics | 4:持股變動聲明-高管 Burnett Patrick
美股sec公告 ·  05/03 16:29
Moomoo AI 已提取核心訊息
Patrick Burnett, associated with Arcutis Biotherapeutics, Inc. [ARQT], completed a sale of 9,555 shares of common stock on May 2, 2024. The transaction was executed in the open market at a price of $8.7378 per share, resulting in a total sale value of approximately $83,489.68. Following the sale, Burnett's direct holdings in the company amount to 259,745 shares of common stock.
Patrick Burnett, associated with Arcutis Biotherapeutics, Inc. [ARQT], completed a sale of 9,555 shares of common stock on May 2, 2024. The transaction was executed in the open market at a price of $8.7378 per share, resulting in a total sale value of approximately $83,489.68. Following the sale, Burnett's direct holdings in the company amount to 259,745 shares of common stock.
與Arcutis Biotherapeutics, Inc. [ARQT] 相關的帕特里克·伯內特於2024年5月2日完成了9,555股普通股的出售。該交易在公開市場上以每股8.7378美元的價格執行,總銷售價值約爲83,489.68美元。出售後,伯內特在該公司的直接持有量爲259,745股普通股。
與Arcutis Biotherapeutics, Inc. [ARQT] 相關的帕特里克·伯內特於2024年5月2日完成了9,555股普通股的出售。該交易在公開市場上以每股8.7378美元的價格執行,總銷售價值約爲83,489.68美元。出售後,伯內特在該公司的直接持有量爲259,745股普通股。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息